TRT’s Burn-In Thesis Is Still Intact
$TRT is down roughly 45% from its $21.38 high and now trades under $12. Everyone thinks the thesis broke. The business says otherwise.
Nine-month revenue nearly doubled from $26M to $48M, the company swung to an operating profit, and it landed a $5.3M order for burn-in boards on a major AI-chip program.
The key distinction is between a weak tape and a broken business. Burn-in testing is a bottleneck as advanced chips become more expensive and complex. TRT sits in the test layer that customers cannot simply skip.
The market is discounting a cyclical pause. The operating data still points to share gains and a credible path to scale.
